Your genes could hold the key to better depression treatment
NCT ID NCT07738497
First seen Jul 31, 2026 · Last updated Jul 31, 2026
Summary
This trial is testing whether using a genetic test to choose antidepressants leads to better outcomes for people with major depressive disorder. Half of the 220 participants will have their treatment guided by a cheek swab that analyzes genes affecting drug metabolism, while the other half will receive standard care. The study will compare response rates, side effects, and how often medication adjustments are needed over 12 weeks, with the goal of moving toward more personalized depression care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Pharmacogenomic testing (genetic test from a cheek swab) to guide antidepressant selection
- What this could lead to
- If successful, this could make depression treatment more personalized, helping doctors choose the right antidepressant based on a patient's genes, potentially improving response rates and reducing side effects.
- What could go wrong
- The trial is relatively small and early, and genetic testing may not always predict real-world drug response. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who returns to work after stress treatment?
- Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Can a Three-Session therapy rival CBT for Event-Related depression?
- A therapy that aims to boost wellbeing, not just ease symptoms — a trial puts it to the test
- Eye movements may reveal who benefits from depression medication